To view the latest corporate presentation please click here…
Corporate presentation May 2019
ARM Cell & Gene : Meeting on the Med April 2019
Association for research in vision and ophthalmology (ARVO) annual meeting 2019 : Jason Commander presentation
Proactive investors ‘ReNeuron Group agrees £80mln cell therapy licensing deal for China’
H.C. Wainwright & Co. global life sciences conference
ReNeuron will be presenting at the H.C. Wainwright & Co. global life sciences conference in London on April 9th, 2019.
Details of the conference can be found on our Events page.
The ReNeuron presentation can be accessed by webcast on April 9, 2019 3:30 p.m. (BST)
arm investor day webcast New York March 21, 2019
Corporate Presentation March 2019
To view the latest corporate presentation please click here.
Alliance for Regenerative Medicine : Cell & Gene investor day
Olav Hellebo, ReNeuron CEO will be presenting via webcast at the Alliance for Regenerative Medicine : Cell & Gene investor day on March 21, 2019.
ReNeuron’s slot is approximately 9.10am Eastern time (approx. 1.10 pm UK time)
To listen, please follow the link to access further information
Proactive Investors ‘ReNeuron provides encouraging update to phase II eye disease trial’
Proactive Investors ‘ReNeuron Group’s phase IIb stroke trial kicks off with first patient treated’